1. Home
  2. CFBK vs INGN Comparison

CFBK vs INGN Comparison

Compare CFBK & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CF Bankshares Inc.

CFBK

CF Bankshares Inc.

HOLD

Current Price

$27.80

Market Cap

184.4M

Sector

Finance

ML Signal

HOLD

Logo Inogen Inc

INGN

Inogen Inc

HOLD

Current Price

$6.11

Market Cap

168.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CFBK
INGN
Founded
1892
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Industrial Specialties
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
184.4M
168.6M
IPO Year
2005
2013

Fundamental Metrics

Financial Performance
Metric
CFBK
INGN
Price
$27.80
$6.11
Analyst Decision
Buy
Strong Buy
Analyst Count
1
3
Target Price
$29.00
$11.00
AVG Volume (30 Days)
41.7K
233.0K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
1.30%
N/A
EPS Growth
30.58
43.42
EPS
2.69
N/A
Revenue
N/A
$348,668,000.00
Revenue This Year
$32.28
$7.92
Revenue Next Year
N/A
$7.86
P/E Ratio
$10.28
N/A
Revenue Growth
N/A
3.86
52 Week Low
$19.22
$5.34
52 Week High
$34.34
$9.13

Technical Indicators

Market Signals
Indicator
CFBK
INGN
Relative Strength Index (RSI) 40.67 48.02
Support Level $23.49 $5.95
Resistance Level $29.95 $6.19
Average True Range (ATR) 0.69 0.24
MACD -0.05 -0.00
Stochastic Oscillator 33.75 19.70

Price Performance

Historical Comparison
CFBK
INGN

About CFBK CF Bankshares Inc.

CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.

About INGN Inogen Inc

Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.

Share on Social Networks: